Advertisement
Person › Details
Gabriel Baertschi (Grünenthal GmbH)
Baertschi, Gabriel (Grünenthal 201610– CEO before President AstraZeneca Japan + Managing Director AstraZeneca GmbH)
Organisation | Grünenthal GmbH | |
Group | Grünenthal (Group) | |
Former/major organisation | AstraZeneca Japan | |
Group | AstraZeneca (Group) | |
Product | pharmaceutical | |
Record changed: 2021-04-20 |
Advertisement
More documents for Gabriel Baertschi
- [1] Grünenthal GmbH. (10/30/18). "Press Release: Grünenthal Agrees US$ 922 m Deal with AstraZeneca for Nexium and Vimovo". Aachen....
- [2] Grünenthal GmbH. (9/1/17). "Press Release: Mark Fladrich Takes Office as the New CCO of the Grünenthal Group". Aachen....
- [3] Grünenthal GmbH. (6/7/17). "Press Release: Grünenthal Enters Agreement with AstraZeneca to Acquire Global Rights to Migraine Treatment Zomig (Zolmitriptan)". Aachen: Athenäum....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top